Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1982 1
1984 5
1985 2
1986 3
1987 4
1988 10
1989 4
1991 4
1992 1
1993 9
1994 9
1995 13
1996 11
1997 15
1998 9
1999 12
2000 8
2001 10
2002 13
2003 18
2004 22
2005 25
2006 24
2007 19
2008 30
2009 31
2010 34
2011 37
2012 39
2013 38
2014 35
2015 46
2016 50
2017 45
2018 47
2019 52
2020 70
2021 53
Text availability
Article attribute
Article type
Publication date

Search Results

763 results
Results by year
Filters applied: . Clear all
Page 1
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Satouchi M, Nosaki K, Takahashi T, Nakagawa K, Aoe K, Kurata T, Sekine A, Horiike A, Fukuhara T, Sugawara S, Umemura S, Saka H, Okamoto I, Yamamoto N, Sakai H, Kishi K, Katakami N, Horinouchi H, Hida T, Okamoto H, Atagi S, Ohira T, Han SR, Noguchi K, Ebiana V, Hotta K. Satouchi M, et al. Among authors: ohira t. Cancer Sci. 2020 Dec;111(12):4480-4489. doi: 10.1111/cas.14647. Epub 2020 Oct 16. Cancer Sci. 2020. PMID: 32926507 Free PMC article. Clinical Trial.
Obesity and mental health improvement following nutritional education focusing on gut microbiota composition in Japanese women: a randomised controlled trial.
Uemura M, Hayashi F, Ishioka K, Ihara K, Yasuda K, Okazaki K, Omata J, Suzutani T, Hirakawa Y, Chiang C, Aoyama A, Ohira T. Uemura M, et al. Among authors: ohira t. Eur J Nutr. 2019 Dec;58(8):3291-3302. doi: 10.1007/s00394-018-1873-0. Epub 2018 Dec 6. Eur J Nutr. 2019. PMID: 30523432 Clinical Trial.
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M. Tamura R, et al. Among authors: ohira t. Nat Commun. 2019 Dec 17;10(1):5758. doi: 10.1038/s41467-019-13640-1. Nat Commun. 2019. PMID: 31848332 Free PMC article. Clinical Trial.
Effect of phytoncide from trees on human natural killer cell function.
Li Q, Kobayashi M, Wakayama Y, Inagaki H, Katsumata M, Hirata Y, Hirata K, Shimizu T, Kawada T, Park BJ, Ohira T, Kagawa T, Miyazaki Y. Li Q, et al. Among authors: ohira t. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):951-9. doi: 10.1177/039463200902200410. Int J Immunopathol Pharmacol. 2009. PMID: 20074458 Free article. Clinical Trial.
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
Sakai K, Tsuboi M, Kenmotsu H, Yamanaka T, Takahashi T, Goto K, Daga H, Ohira T, Ueno T, Aoki T, Nakagawa K, Yamazaki K, Hosomi Y, Kawaguchi K, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Saeki S, Sugio K, Nishio M, Okabe K, Yamamoto N, Nishio K. Sakai K, et al. Among authors: ohira t. Cancer Sci. 2021 Jan;112(1):388-396. doi: 10.1111/cas.14730. Epub 2020 Nov 30. Cancer Sci. 2021. PMID: 33185928 Free PMC article. Clinical Trial.
Predicting osimertinib-treatment outcomes through EGFR mutant-fraction monitoring in the circulating tumor DNA of EGFR T790M-positive patients with non-small cell lung cancer (WJOG8815L).
Sakai K, Takahama T, Shimokawa M, Azuma K, Takeda M, Kato T, Daga H, Okamoto I, Akamatsu H, Teraoka S, Ono A, Ohira T, Yokoyama T, Yamamoto N, Nakagawa K, Nishio K. Sakai K, et al. Among authors: ohira t. Mol Oncol. 2021 Jan;15(1):126-137. doi: 10.1002/1878-0261.12841. Epub 2020 Nov 17. Mol Oncol. 2021. PMID: 33131198 Free PMC article.
763 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page